BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 3167840)

  • 1. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
    Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
    Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
    Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum?
    Jordan SJ; Green AC; Whiteman DC; Webb PM;
    Gynecol Oncol; 2007 Nov; 107(2):223-30. PubMed ID: 17662378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous melanoma in relation to exogenous hormones and reproductive factors.
    Holly EA; Weiss NS; Liff JM
    J Natl Cancer Inst; 1983 May; 70(5):827-31. PubMed ID: 6573527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking and risk of epithelial ovarian cancer.
    Rossing MA; Cushing-Haugen KL; Wicklund KG; Weiss NS
    Cancer Causes Control; 2008 May; 19(4):413-20. PubMed ID: 18080774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation of reproductive factors to mortality from breast cancer.
    Daling JR; Malone KE; Doody DR; Anderson BO; Porter PL
    Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):235-41. PubMed ID: 11895871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.
    Rossing MA; Tang MT; Flagg EW; Weiss LK; Wicklund KG
    Am J Epidemiol; 2004 Dec; 160(11):1070-8. PubMed ID: 15561986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for ovarian cancer in central Italy.
    Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
    Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
    McGuire V; Felberg A; Mills M; Ostrow KL; DiCioccio R; John EM; West DW; Whittemore AS
    Am J Epidemiol; 2004 Oct; 160(7):613-8. PubMed ID: 15383404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for benign serous and mucinous epithelial ovarian tumors.
    Jordan SJ; Green AC; Whiteman DC; Webb PM
    Obstet Gynecol; 2007 Mar; 109(3):647-54. PubMed ID: 17329516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer.
    Wittenberg J; Cook LS; Rossing MA; Weiss NS
    Epidemiology; 1999 Nov; 10(6):761-3. PubMed ID: 10535792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Events of reproductive life and the incidence of epithelial ovarian cancer.
    Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
    Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
    Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and epithelial ovarian cancer. Does dose matter?
    Sanderson M; Williams MA; Weiss NS; Hendrix NW; Chauhan SP
    J Reprod Med; 2000 Sep; 45(9):720-6. PubMed ID: 11027080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.